FierceBiotech
  • FierceBiotech
  • FierceBiotechIT
  • FierceBiotechResearch
  • FierceBiomarkers
  • FierceDrugDelivery
  • FierceMedicalDevices
  • FierceVaccines
  • FiercePharma
  • FiercePharmaManufacturing
  • FierceCRO
  • More Fierce Network sites
  • Select another site
  • Advertise
  • Contact

Free Daily Biotech Industry Newsletter Get the latest on Biotech & Pharma Deals, Clinical Trials, FDA Decisions, and Key Regulatory Issues sent straight to your Inbox. Join over 100,000 biotech professionals who subscribe to FierceBiotech for FREE! Click here to see a sample.

FierceBiotech

  • News
  • TOPICS
    • Biosimilars
    • Chutes and Ladders
    • Clinical Trials
    • Drug Safety
    • Emerging Markets
    • Europe
    • M&A
    • Outsourcing
    • Partnering
    • Personalized Medicine
    • Pipeline
    • R&D
    • Regulatory
  • ANALYSIS
    • Third Rock's Levin calls for teamwork in personalized medicine
      by Damian Garde
    • Readers' picks, responses to Fierce's 'Top 10' cancer drugs report
      by Ryan McBride
    • More commentary
  • FEATURES
    • The Biggest R&D Spenders in Biotech
    • The Biggest R&D Spenders In Biopharma
    • Top 10 Late-Stage Cancer Drugs – 2012
  • LIBRARY
    • Webinars
    • View All
  • EVENTS
  • JOBS
    • Browse Jobs
    • Post a Job
  • Marketplace
  • Susbscribe
  • Twitter
  • Mobile
Follow US
Tag:

Uloric

Latest Headlines

Latest Headlines

FDA approves first new gout drug in 40 years

February 17, 2009
Breaking a therapeutic drought that has stretched over more than four decades, Takeda says it has won the FDA's approval of its new gout drug Uloric . Gout affects more than five million Americans who

Related Tags

  • Ardea BioSciences
  • Takeda
  • FDA approval
  • gout

Uloric Press Releases

  • Takeda’s Uloric Continues to Make Inroads among Moderate to Severe Gout Patients, but Allopurinol Holds a Vast Market Shar
  • Metabolex Initiates Phase 2 Trial of Arhalofenate
  • Ardea Biosciences Reports Recent Accomplishments and Third Quarter and Year-to-Date 2010 Financial Results
  • Ardea Biosciences Announces Positive Results for RDEA594 in Combination with Febuxostat or Allopurinol in Gout Patients
  • FDA Approves ULORIC(R) (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout

Join 100,000+ Insiders SIGN UP FOR OUR NEWSLETTER

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

  • MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
  • Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
  • What's your BIO?June 18-21, 2012 — Boston, MA
MORE EVENTS

Press Releases

  • T cells 'hunt' parasites like animal predators seek prey, study shows
  • UC San Diego Researchers Receive New CIRM Funding
  • Same gene that stunts infants' growth also makes them grow too big
  • Chronic Pain Is Relieved by Cell Transplantation in Lab Study
  • Drug-vaccine combo better for breast cancer
  • More Press Releases

Featured Jobs

  • Pilot Manufacturing Scientist Job
    Yoh - Cambridge, MA, USA
  • Analytical Scientist Job
    Yoh - Durham, NC, USA
  • Sr. IT Infrastructure Architect Job
    Celgene Corporation - Berkeley Heights, NJ, US
  • Director, Safety Pharmacology and Toxicology
    Tesaro - Waltham, MA
  • Director, Human Resources
    TESARO - Waltham, MA

A publication of FierceMarkets

FierceBiotech monitors biotech & pharma deals, FDA decisions, clinical trials, and more. Join more than 100,000 biotech industry leaders who subscribe to our free daily email. Click here to get your free weekly email briefing today!

The FierceMarkets Network:

Telecom
  • FierceWireless
  • FierceBroadbandWireless
  • FierceMobileContent
  • FierceDeveloper
  • FierceWireless:Europe
  • FierceTelecom
  • FierceEnterpriseCommunications
  • FierceIPTV
  • FierceOnlineVideo
  • FierceCable
Healthcare
  • FierceHealthcare
  • FiercePracticeManagement
  • FierceHealthIT
  • FierceHealthFinance
  • Hospital Impact
  • FierceEMR
  • FierceMobileHealthcare
  • FierceHealthPayer
Government
  • FierceGovernment
  • FierceGovernmentIT
  • FierceHomelandSecurity
Energy
  • FierceEnergy
  • FierceSmartGrid
Life Sciences
  • FierceBiotech
  • FierceBiotechResearch
  • FiercePharma
  • FierceVaccines
  • FierceBiotechIT
  • FiercePharmaManufacturing
  • FierceMedicalDevices
  • FierceDrugDelivery
  • FierceBiomarkers
  • FierceCRO
Enterprise IT
  • FierceCIO
  • FierceCIO:TechWatch
  • FierceMobileIT
  • FierceContentManagement
Finance
  • FierceFinance
  • FierceComplianceIT
  • FierceFinanceIT
  • Home
  • Subscribe
  • Advertise
  • Mobile Edition
  • RSS
  • Privacy
  • Editors
© 2012 FierceMarkets. All rights reserved.